Roberto Saenz, OD
Corneal and Contact Management · San Antonio, TXNPI 1821440280
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Glaukos Corporation at 27.1% of the total. Reporting peaked in 2023 at $59,285 and has fallen 75.9% since, to $14,274 in 2025. Among corneal and contact management clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 370 payments — averaging $463.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$47K
- Biotissue Holdings Inc.$25K
- Sight Sciences, Inc.$25K
- Oyster Point Pharma, Inc.$18K
- AbbVie$14K
- Johnson & Johnson Surgical Vision, Inc.$11K
- plus $31K from 23 others
Across 32 payments — averaging $22,233 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$299K
- Sight Sciences, Inc.$291K
- Sun Pharmaceutical Industries Inc.$74K
- Ocular Therapeutix, Inc.$48K
What the payments were for
- Consulting fees$62,77537%
- Speaking & faculty fees$87,60251%
- Travel & lodging$10,5466%
- Food & beverage$10,4606%
- Gifts$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 64 | $46,509 |
| Biotissue Holdings Inc. | 29 | $25,185 |
| Sight Sciences, Inc. | 25 | $25,023 |
| Oyster Point Pharma, Inc. | 34 | $18,089 |
| AbbVie(2 entities) | 48 | $14,146 |
| Johnson & Johnson Surgical Vision, Inc. | 29 | $10,966 |
| Carl Zeiss Meditec, Inc. | 7 | $10,168 |
| Kala Pharmaceuticals, Inc. | 13 | $5,954 |
| Lensar, Inc. | 4 | $5,714 |
| Novartis | 17 | $2,144 |
| Alcon | 26 | $1,711 |
| Quidel Corporation | 5 | $1,366 |
| Rxsight Inc | 18 | $1,304 |
| Amgen | 3 | $1,213 |
| Tarsus Pharmaceuticals, Inc. | 3 | $294 |
| Lumenis, Inc | 1 | $267 |
| Carl Zeiss Meditec USA, Inc. | 6 | $255 |
| Sun Pharmaceutical Industries Inc. | 10 | $208 |
| Bausch & Lomb Americas Inc. | 3 | $184 |
| Harrow Eye, LLC | 2 | $150 |
| Shire North American Group Inc | 5 | $129 |
| EMD Serono, Inc. | 1 | $118 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $109 |
| Staar Surgical Company | 3 | $55 |
| Dompe US, Inc. | 2 | $45 |
| Ocular Therapeutix, Inc. | 2 | $37 |
| Thea Pharma Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Oasis Medical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$20,672
- TYRVAYA$17,554
- TEARCARE SYSTEM$17,016
- KXL System$13,091
- VUITY$8,872
- TearScience Lipiflow System$8,250
- VisuMax$6,832
- Catalys Laser System$6,600
- TearScience Lipiscan System$6,600
- TearScience Lipiview System$6,600
- Tecnis Multifocal Family of 1-piece IOLS$6,600
- EYSUVIS$5,885
- iStent inject W$5,700
- AmnioGraft$5,696
- LENSAR LASER SYSTEM$5,696
- iStent inject Trabecular Micro-Bypass Stent System$5,502
- TearCare$5,500
- ILINK$5,025
- iStent Trabecular Micro-Bypass Stent System$5,002
- AmnioGuard$3,200
How this compares
$171,399 in reported general payments places this provider in the 95th percentile of 103 corneal and contact management providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other corneal and contact management in San Antonio
- Jack AbramsonSan Antonio$5K
- Anthony MacSan Antonio$5K
- Louis PetersSan Antonio$4K
- Kristen KautzmanSan Antonio$3K
- Maurice WilsonConroe$362K
- Fariba ParmerGrapevine$26K
- Vissett SunHouston$13K
- Napoleon LoveroHouston$12K
- Sairah MalikHouston$10K
- Darlene JonesPlano$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.